KCNA1 gain‐of‐function epileptic encephalopathy treated with 4‐aminopyridine.

MLA

Müller, Peter, et al. “KCNA1 Gain‐of‐function Epileptic Encephalopathy Treated with 4‐aminopyridine.” Annals of Clinical & Translational Neurology, vol. 10, no. 4, Apr. 2023, pp. 656–63. EBSCOhost, https://doi.org/10.1002/acn3.51742.

APA

Müller, P., Takacs, D. S., Hedrich, U. B. S., Coorg, R., Masters, L., Glinton, K. E., Dai, H., Cokley, J. A., Riviello, J. J., Lerche, H., & Cooper, E. C. (2023). KCNA1 gain‐of‐function epileptic encephalopathy treated with 4‐aminopyridine. Annals of Clinical & Translational Neurology, 10(4), 656–663. https://doi.org/10.1002/acn3.51742

Chicago

Müller, Peter, Danielle S. Takacs, Ulrike B. S. Hedrich, Rohini Coorg, Laura Masters, Kevin E. Glinton, Hongzheng Dai, et al. 2023. “KCNA1 Gain‐of‐function Epileptic Encephalopathy Treated with 4‐aminopyridine.” Annals of Clinical & Translational Neurology 10 (4): 656–63. doi:10.1002/acn3.51742.